- Free from Publisher JM Miles, L Leiter, P Hollander, T Wadden, JW … - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—After 1 year of treatment, mean (±SE) weight loss was greater in the
orlistat than in the placebo group (−4.6 ± 0.3% vs. −1.7 ± 0.3% of
baseline wt, P < 0.001). Orlistat treatment caused a greater improvement in ... Cited by 171 - Related articles - BL Direct - All 7 versions
- Free from Publisher DE Kelley, GA Bray, FX Pi-Sunyer, S Klein, J … - Diabetes Care, 2002 - Am Diabetes Assoc OBJECTIVE—Weight loss improves glycemic control, lipid profiles, and blood
pressure in patients with type 2 diabetes. However, successful long-term weight
loss is difficult for these patients, particularly those treated with ... Cited by 172 - Related articles - BL Direct - All 7 versions
M Hanefeld, G Sachse - Diabetes Obesity and Metabolism, 2002 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 80 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org [PDF] PA Hollander, SC Elbein, IB Hirsch, D Kelley … - Diabetes care, 1998 - Am Diabetes Assoc Obesity is a significant cause of type 2 diabetes (1,2). It is also the most
impo rtant modifiable factor for this disease in both men and women (3). The
incidence of type 2 diabetes rises with inc reasing severity of obesity, ... Cited by 541 - Related articles - BL Direct - All 6 versions
F Lindgarde - Journal of internal medicine, 2000 - interscience.wiley.com *H. Hildefors, VC Eden Malmö; A. Kohlström, Lundens Läkargrupp Malmö; U.-B.
Eriksson, Läkargruppen Gustaf Adolf Malmö; S. Jönsson and J. Kosjerina,
Linnero VC Lund; R. Ekesbo, VC Dalby; U. Pettersson, Ekaryd Söderåkra; E. ... Cited by 126 - Related articles - BL Direct - All 6 versions
- Free from Publisher SJ McNulty, E Ur, G Williams - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—Sibutramine induced significant weight loss (P < 0.001) with both 15
mg/day (5.5 ± 0.6 kg at 12 months) and 20 mg/day (8.0 ± 0.9 kg), whereas
placebo did not (0.2 ± 0.5 kg). Weight loss ≥10% was achieved by 14 and ... Cited by 98 - Related articles - BL Direct - All 6 versions
I Broom, J Wilding, P Stott, N Myers - International journal of clinical practice(Esher), 2002 - cat.inist.fr The potential effect of orlistat on cardiovascular co-morbidities may have been
previously underestimated. This study assesses the efficacy of orlistat therapy
for weight loss and cardiovascular risk factor reduction in obese patients ... Cited by 40 - Related articles - BL Direct - All 3 versions
J Hauptman, C Lucas, MN Boldrin, H Collins, … - Archives of Family Medicine, 2000 - Am Med Assoc Participants A group of 796 obese patients (body mass index, 30-44 kg/m 2 ),
treated with placebo 3 times a day (TID), 60 mg of orlistat TID, or 120 mg of
orlistat TID, in conjunction with a reduced-energy diet for the first year ... Cited by 205 - Related articles - BL Direct - All 5 versions
N Finer, WP James, PG Kopelman, ME Lean, … - International journal of obesity and related metabolic …, 2000 - ncbi.nlm.nih.gov 1: Int J Obes Relat Metab Disord. 2000 Mar;24(3):306-13. One-year treatment
of obesity: a randomized, double-blind, placebo-controlled ... Cited by 186 - Related articles - BL Direct - All 3 versions
G Bakris, D Calhoun, B Egan, C Hellmann, M … - Journal of hypertension, 2002 - journals.lww.com Page 1. Orlistat improves blood pressure control in obese subjects with treated
but inadequately controlled hypertension George Bakrisa ... Cited by 51 - Related articles - BL Direct - All 5 versions
